top
Search terms
Results 1 - 10 of 28 - ordered by :
Pages: 1 2 3
Ehjournal

Frontiers in heart failure: assessement, risk factors, and novel genetic and cell-based therapies Heart failure is commonly divided into two entities, i.e. heart failure with preserved14 and heart ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/06/2016
Ehjournal

The metabolic syndrome not only precedes cardiovascular conditions, and hence represents an important cluster of risk factors,1,2 but also remains relevant in patients with established coronary ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/10/2015 Item size : 195267 bytes
Ehjournal

Of note, patients with atrial fibrillation and heart failure have a higher risk of thrombo-embolic events and overall mortality compared with those with atrial fibrillation without heart failure as ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/08/2016 Item size : 162473 bytes
Ehjournal

Furthermore, the EMPA-REG OUTCOME trial using the novel antihyperglycaemic agent, empagliflozin,8 a selective sodiumglucose co- transporter inhibitor, significantly reduced cardiovascular mortality; ...

European Heart Journal, Lüscher, Thomas F.

Date : 07/02/2016 Item size : 183395 bytes
Ehjournal

While the latter has a well-defined aetiology, i.e. ischaemia and infarction with subsequent loss of contractility and remodelling, the definition of dilated cardiomyopathies is less clear, although ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/06/2016 Item size : 231489 bytes
Ehjournal

[...]in coronary artery disease, not only lipids matter, but inflammation is about to become a major therapeutic target.4 Inflammation involves cellular and humoral factors.5,6 Thus, knowledge of ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/03/2016 Item size : 161003 bytes
Ehjournal

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast Atrial fibrillation in its paroxysmal or permanent form is the most common arrhythmia and it will probably become even more common ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/05/2016
Ehjournal

Furthermore, in stable coronary artery disease and ischaemic cardiomyopathy, heart rate is a well-established determinant of ischaemia, and its reduction is a recognized strategy for symptom relief ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/08/2015
Ehjournal

Specifically, (i) the scope is limited to randomized trials only, which excludes a significant body of data and promotes essentially a statin centric approach only; (ii) the abolition of low-density ...

European Heart Journal, Ray, Kausik K., Kastelein, John J. P., Matthijs Boekholdt, S., Nicholls, Stephen J., Khaw, Kay-Tee, Ballantyne, Christie M., Catapano, Alberico L., Reiner, Željko, ...

Date : 14/04/2014 Item size : 240869 bytes
Ehjournal

In less than two decades, valvular heart disease has seen a true revival in cardiovascular medicine since the first percutaneous replacement of a pulmonary valve by Philipp Bonhoeffer in 2000,1 and ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/04/2017 Item size : 107584 bytes